Gary Andrew Weisman

University of Missouri-Columbia

NIH Rank #12795
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$1.1M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#12,795
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.1M across 3 grants · National rank #12795.

Top grants by award amount

Gary Andrew Weisman's NIH grant portfolio, ranked by award amount.

  • 5R01DE029833-04R01
    Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome
    $582.7K
    award amount
  • 5R01DE032032-02R01
    The P2X7 receptor for ATP as a therapeutic target in the prevention of radiation-induced salivary gland dysfunction
    $506.4K
    award amount
  • 3R01DE029833-04S1R01
    Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome
    $59.7K
    award amount

Affiliation

Institutions that have administered grants for Gary Andrew Weisman.

Affiliated with University of Missouri-Columbia (MO).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    University of Missouri-Columbia
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding